ArticleOncoTargets and therapy2021

CircHIPK2 Contributes to DDP Resistance and Malignant Behaviors of DDP-Resistant Ovarian Cancer Cells Both in vitro and in vivo Through circHIPK2/miR-338-3p/CHTOP ceRNA Pathway.

Yang Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.